Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Shattuck Labs, Inc.

Get SEC filing alerts via email and in your feed for Shattuck Labs, Inc.

STTK

Shattuck Labs, Inc.

About Shattuck Labs, Inc.

Shattuck Labs, Inc. is a biotechnology company focused on developing innovative treatments for inflammatory and immune-mediated diseases. Its lead program, SL-325, is a high-affinity monoclonal antibody targeting the DR3 receptor to inhibit the TL1A pathway, aiming to treat conditions like IBD. The company leverages protein engineering, advances biologics into clinical trials, and collaborates with biopharma partners to create first-in-class immunotherapies.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Shattuck Labs, Inc.

1
1
Shattuck Labs, Inc. Shattuck Labs Reports $14.8 Million Net Loss and No Revenue in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Shattuck Labs, Inc. Shattuck Labs Reports $48.8 Million Net Loss for Fiscal Year 2025, Focuses on Clinical Trials

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Shattuck Labs, Inc. Shattuck Labs Reports 66.6% Revenue Decline and 36.2% Improvement in Net Loss for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Shattuck Labs, Inc. Shattuck Labs Reports Zero Revenue and $12.5 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Shattuck Labs, Inc. Shattuck Labs Reports $13.7 Million Net Loss in Q1 2025, Revenue Drops to $0

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Shattuck Labs, Inc. Shattuck Labs Reports $75.4M Net Loss and $5.7M Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Shattuck Labs, Inc. Shattuck Labs Reports Revenue Growth, Improved Losses, and Restructuring Efforts in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments